Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Daniel Mullins

Showing results (171-180 of 333) with videos related to

Pageof 34
Sort By:
Journal of the National Medical Association|February 28, 2012
Lessons learned from community-based minority health care serving system participation in an NIH clinical trialCamellus O Ezeugwu, Aurelia Laird, C Daniel Mullins, et al.
The Oncologist|April 30, 2016
Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon CancerKaloyan A Bikov, C Daniel Mullins, Anna Hung, et al.
Archives of Physical Medicine and Rehabilitation|July 10, 2017
Perception of Barriers to the Diagnosis and Receipt of Treatment for Neuropsychiatric Disturbances After Traumatic Brain InjuryJennifer S Albrecht, Lyndsay M O'Hara, Kara A Moser, et al.
Future Oncology (London, England)|August 2, 2021
Pragmatic patient engagement in designing pragmatic oncology clinical trialsBernard Bright Davies-Teye, Michelle Medeiros, Cynthia Chauhan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Impact of the fourth hurdle on the international pharmaceutical industryC Daniel Mullins, Elizabeth M Ndiritu, David M Yoder, et al.
The American Journal of Managed Care|April 10, 2009
The total economic burden of overactive bladder in the United States: a disease-specific approachEbere Onukwugha, Ilene H Zuckerman, Diane McNally, et al.
Journal of Managed Care Pharmacy : JMCP|June 7, 2005
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treatC Daniel Mullins, Kathleen A Weis, Eleanor M Perfetto, et al.
Journal of Managed Care & Specialty Pharmacy|March 1, 2019
Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management ToolsAnna Hung, C Daniel Mullins, Julia F Slejko, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Costs of Medical Care Among Augmentation Therapy Users and Non-Users with Alpha-1 Antitrypsin Deficiency in the United StatesJan Sieluk, Joseph Levy, Robert A Sandhaus, et al.
Urologic Oncology|January 3, 2017
Specialist visits and initiation of cancer-directed treatment among a large cohort of men diagnosed with prostate cancerEberechukwu Onukwugha, Candice Yong, Michael Naslund, et al.
Pageof 34

Showing results (171-180 of 333) with videos related to

Sort By:
Pageof 34
Journal of the National Medical Association|February 28, 2012
Lessons learned from community-based minority health care serving system participation in an NIH clinical trialCamellus O Ezeugwu, Aurelia Laird, C Daniel Mullins, et al.
The Oncologist|April 30, 2016
Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon CancerKaloyan A Bikov, C Daniel Mullins, Anna Hung, et al.
Archives of Physical Medicine and Rehabilitation|July 10, 2017
Perception of Barriers to the Diagnosis and Receipt of Treatment for Neuropsychiatric Disturbances After Traumatic Brain InjuryJennifer S Albrecht, Lyndsay M O'Hara, Kara A Moser, et al.
Future Oncology (London, England)|August 2, 2021
Pragmatic patient engagement in designing pragmatic oncology clinical trialsBernard Bright Davies-Teye, Michelle Medeiros, Cynthia Chauhan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Impact of the fourth hurdle on the international pharmaceutical industryC Daniel Mullins, Elizabeth M Ndiritu, David M Yoder, et al.
The American Journal of Managed Care|April 10, 2009
The total economic burden of overactive bladder in the United States: a disease-specific approachEbere Onukwugha, Ilene H Zuckerman, Diane McNally, et al.
Journal of Managed Care Pharmacy : JMCP|June 7, 2005
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treatC Daniel Mullins, Kathleen A Weis, Eleanor M Perfetto, et al.
Journal of Managed Care & Specialty Pharmacy|March 1, 2019
Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management ToolsAnna Hung, C Daniel Mullins, Julia F Slejko, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Costs of Medical Care Among Augmentation Therapy Users and Non-Users with Alpha-1 Antitrypsin Deficiency in the United StatesJan Sieluk, Joseph Levy, Robert A Sandhaus, et al.
Urologic Oncology|January 3, 2017
Specialist visits and initiation of cancer-directed treatment among a large cohort of men diagnosed with prostate cancerEberechukwu Onukwugha, Candice Yong, Michael Naslund, et al.
Pageof 34